HOWL - Werewolf Therapeutics Inc
IEX Last Trade
2.14
-0.080 -3.738%
Share volume: 150,977
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$2.22
-0.08
-3.60%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-11 | 2022-11-10 | 2023-03-23 | 2023-05-11 | 2023-08-10 | 2023-11-14 | 2024-03-07 | 2024-05-03 | |
| Assets | |||||||||
| Total Assets | 175.329 M | 172.424 M | 160.245 M | 195.069 M | 185.235 M | 176.386 M | 174.833 M | 177.600 M | |
| Current Assets | 154.165 M | 151.587 M | 140.200 M | 156.562 M | 147.399 M | 139.258 M | 138.370 M | 142.284 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 6.233 M | 6.837 M | 3.957 M | 2.439 M | 3.020 M | 3.289 M | 2.677 M | 2.320 M | |
| Short Term Investments | 6.233 M | 6.837 M | 3.957 M | 2.439 M | 3.020 M | 3.289 M | 2.677 M | 2.320 M | |
| Total Receivables | 2.220 M | 4.300 M | 6.928 M | 6.255 M | 6.927 M | 5.911 M | 1.350 M | 775.000 K | |
| Current Cash | 145.712 M | 140.450 M | 129.315 M | 147.868 M | 137.452 M | 130.058 M | 134.343 M | 139.189 M | |
| Total Non-current Assets | 21.164 M | 20.837 M | 20.045 M | 38.507 M | 37.836 M | 37.128 M | 36.463 M | 35.316 M | |
| Property Plant Equipment | 9.031 M | 9.169 M | 8.988 M | 8.699 M | 8.381 M | 8.342 M | 7.958 M | 7.529 M | |
| Other Assets | 10.925 M | 10.457 M | 9.843 M | 8.797 M | 8.440 M | 7.767 M | 7.482 M | 6.760 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 175.329 M | 172.424 M | 160.245 M | 195.069 M | 185.235 M | 176.386 M | 174.833 M | 177.600 M | |
| Total liabilities | 45.488 M | 41.477 M | 37.908 M | 73.996 M | 66.636 M | 63.943 M | 63.459 M | 60.013 M | |
| Total current liabilities | 30.368 M | 27.800 M | 23.989 M | 21.722 M | 15.006 M | 14.439 M | 19.378 M | 21.214 M | |
| Accounts Payable | 2.590 M | 1.388 M | 1.221 M | 2.106 M | 1.490 M | 1.386 M | 1.336 M | 1.594 M | |
| Other liabilities | 1.445 M | 534.000 K | 1.319 M | 1.168 M | 783.000 K | 588.000 K | 433.000 K | 431.000 K | |
| Current long term debt | 1.871 M | 2.020 M | 2.084 M | 2.146 M | 1.970 M | 3.272 M | 8.275 M | 12.903 M | |
| Long term debt | 13.675 M | 13.143 M | 12.600 M | 51.106 M | 50.847 M | 48.916 M | 43.648 M | 38.368 M | |
| Other liabilities | 1.445 M | 534.000 K | 1.319 M | 1.168 M | 783.000 K | 588.000 K | 433.000 K | 431.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 129.841 M | 130.947 M | 122.337 M | 121.073 M | 118.599 M | 112.443 M | 111.374 M | 117.587 M | |
| Common stock | 27.517 M | 29.764 M | 30.782 M | 34.785 M | 35.558 M | 35.654 M | 36.589 M | 41.607 M | |
| Retained earnings | -282.832 M | -294.775 M | -306.705 M | -318.687 M | -323.785 M | -332.070 M | -344.073 M | -360.266 M |